Millions of people are diagnosed with Alzheimer's disease each year, comprising 60% to 70% of dementia cases worldwide. While cognitive impairment and structural brain changes are indicative of ...

Artificial intelligence shows promise for improving care for peripheral artery disease through earlier detection, improved ...

This article explores how AI tools are helping researchers reduce waste, optimize experiments, and accelerate discoveries, ...

ASPET session chair, Dr. Alix Rouault, shared insights into biopharmaceutical drug development and a current obesity ...

Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that it will host ...

Designing a series of sweetener trials seemed straightforward enough to us as behavioural scientists who specialise in human ...

Researchers Launch BHARAT Study: India’s First Large-Scale Search for Aging Biomarkers India is launching one of its most ...

Seventeen young innovators from across Canada are being celebrated as national finalists and national winners of Ingenious+, the Rideau Hall Foundation's youth innovation challenge. Ingenious+ ...

FDA accepted sNDA for IGALMI® use in at-home (outpatient) setting; set Nov. 14, 2026, as PDUFA date Advancing BXCL501 as a potential acute treatment for agitation associated with Alzheimer's dementia ...

What once belonged purely to science fiction is steadily becoming part of everyday life. From automation to advanced tech ...